Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MOB4 pseudogene 2 (MOB4P2) is a noncoding DNA segment in humans that shares sequence similarity with the functional MOB4 gene but contains disabling mutations such as frameshifts or premature stop codons, preventing the production of a functional protein product. As a pseudogene, it is classified as a nonfunctional relative of protein-coding genes, usually arising by duplication or retrotransposition, and is typically untranscribed or transcribed without functional product. There is no evidence for protein-coding potential or biological activity, and MOB4P2 is not known to participate in biologically relevant functions. It is not implicated as a drug target or biomarker, and no evidence implicates MOB4P2 in specific diseases. Most pseudogenes do not have clear disease associations, and while some can produce regulatory noncoding RNAs, no such role is documented for MOB4P2. As a nonfunctional pseudogene, there are also no known safety issues reported. The presence of "pseudogene" in its name signals no expected biological function or direct therapeutic or diagnostic significance, and such entries are often flagged as problematic for target-based drug discovery or disease mechanism studies. MOB4P2 is not a therapeutic target, does not have known functions, interactions, or disease relevance, and is flagged due to its status as a pseudogene and absence of actionable information.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MOB4 pseudogene 2 (MOB4P2).